Subsidiaries

Predictive Therapeutics

Predictive Therapeutics (“PRx”) revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics.

PRx has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression.

PRx uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.

www.predrx.com

Predictive Biotech

Predictive Biotech, Inc. is in the business of creating treatments utilizing the most cutting edge advancements in cellular biology.  The information we collect in collaboration with other research institutes and our clients act as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.

http://predbiotech.com/